Zostavax Lawsuits

Zostavax lawsuits say Merck failed to warn its vaccine could cause side effects. Lawsuits claim people received Zostavax and later suffered shingles, blindness, autoimmune diseases and other related injuries. In August 2018, judges consolidated lawsuits in Pennsylvania and New Jersey.

Zostavax vaccine
Zostavax Lawsuit Facts
  1. Injuries Shingles, autoimmune disorders, spinal cord inflammation, vision problems, hearing loss, death
  2. Top Jury Verdict/Settlement None
  3. Defendant Merck

People who say the Zostavax vaccine injured them are filing lawsuits. Complaints say vaccine maker Merck failed to warn the vaccine could cause side effects.

The vaccine uses a live, weakened form of the chickenpox and shingles virus.

Lawsuits say Merck knew the live virus could cause a painful rash called shingles.

Did You Know?
Merck distributed 36 million doses of Zostavax from 2006 to 2017.

Norman Sukkar was one of the first people to file a lawsuit. He filed his claim in August 2017 in New Jersey. Less than five months after he received Zostavax, he woke up unable to walk. Doctors diagnosed him with acute transverse myelitis — a condition that causes spinal inflammation. He claims Zostavax caused his symptoms.

There are no class actions in the U.S., but Zostavax litigation is ongoing. So far, there have been no trial dates set. Plaintiffs filed the first group of lawsuits in Pennsylvania and New Jersey, and attorneys expect to file more cases.

Complaints Consolidated into Federal Action

On Aug. 2, 2018, the Judicial Panel on Multidistrict Litigation ordered 98 Zostavax lawsuits consolidated into multidistrict litigation (MDL). U.S. District Judge Harvey Bartle III in Pennsylvania will preside over the cases in MDL Number 2848. As of December 2018, there were 335 lawsuits in the MDL.

Attorneys for the plaintiffs commented that Judge Bartle has a lot of experience and has successfully handled other MDLs. Some elderly plaintiffs opposed the decision to consolidate because it may delay their claims. But, judges said consolidating claims would help the group of cases as a whole.

“We are sympathetic to their concerns about the potential for delay,” U.S. District Judge Sarah S. Vance, chair of the Judicial Panel on Multidistrict Litigation, wrote in a transfer order. “But centralization is appropriate if it furthers the expeditious resolution of the litigation taken as a whole, even if some parties might experience inconvenience or delay.”

Attorneys expect to file many more complaints in the federal MDL.

Hundreds of state cases are still pending in California and New Jersey. These are not included in the MDL. Superior Court Judge James F. Hyland is presiding over cases in New Jersey, and on Sept. 27, 2018 he held a case management conference to discuss the discovery timeline, issue a master complaint for all plaintiffs and schedule a day to discuss the science involved in the claims.

So far, there are no trials scheduled or publicized settlements.

Allegations: Vaccine Triggered Shingles, Other Disorders

Zostavax lawsuits claim the vaccine can cause shingles and other injuries. Merck sells Zostavax as a way to prevent the condition. But, some people say the vaccine causes shingles.

According to lawsuits, this type of shingles is more severe and difficult to treat. People claiming shingles from Zostavax must have received their shot after 2006 in order to file a claim.

“A risk of using a live virus vaccine is that it is not weakened enough or ‘under-attenuated.’ Under-attenuated live virus creates an increased risk of developing the disease the vaccine was to prevent.”

Source: Colamesta v. Merck, Case No. 3:18-cv-13832

Other injuries alleged in lawsuits range from elevated blood pressure to serious autoimmune diseases.

For example, Jorja Bentley filed a Zostavax lawsuit in February 2017. Within 24 hours after receiving the vaccine, she developed a headache, dizziness and blurred vision, according to the lawsuit. She continues to suffer right eye injuries, high blood pressure, headaches and

“As a direct result of the vaccine, Plaintiff suffered, is suffering and/or will continue to suffer from mental and emotional distress due to resulting physical limitations and seriousness of her condition,” Bentley’s complaint stated.

The following injuries must have occurred within one year of the vaccination date:
  • Autoimmune disorders, including Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, Meniere’s Disease
  • Bell’s Palsy (facial paralysis)
  • Cardiovascular event
  • Congestive heart failure
  • Death
  • Hearing loss
  • Herpetic Neuralgia (disorder in the nerves)
  • Myelitis (spinal cord inflammation)
  • Pneumonia
  • Postherpetic neuralgia, or PHN (pain continuing after shingles blister subside)
  • Serious neurological diseases or disorders, including brain inflammation (encephalitis)
  • Stroke
  • Vasculitis
  • Vision problems, including blindness, eye infections, retinal damage, acute retinal necrosis
Injured by the Zostavax shingles vaccine? Get a Free Case Review

Zostavax Injuries Not Covered by VICP

Unlike many other vaccines, the National Vaccine Injury Compensation Program (VICP) — a no-fault compensation program — does not cover Zostavax injuries. VICP was set up to provide vaccine manufacturers protection from liability for side effects from vaccines recommended by the Centers for Disease Control and Prevention.

Rather than sue vaccine manufacturers, people injured by vaccines such as the flu, chickenpox or HPV vaccine can submit a claim to the government for compensation. But VICP focuses on vaccines the government recommends for children. So, because the government recommends Zostavax for adults only, VICP does not compensate people hurt by this vaccine. This means people injured by this vaccine may file individual lawsuits against manufacturers.

Merck Accused of Making Defective Vaccine

Merck Logo

Lawsuits accuse Merck of several types of wrongdoing. They say Zostavax “was inherently defective and unreasonably dangerous as designed,” and the manufacturer failed to warn the public. Plaintiffs argue that the shingles virus in the vaccine can reactivate once in the body.

Merck claimed the vaccine could prevent shingles and publicized industry-funded studies in the New England Journal of Medicine in 2005. The study claimed the vaccine would not cause shingles.

Lawsuits also claim that Merck used this false safety data to gain U.S. Food and Drug Administration approval for the vaccine. But after the paper published in NEJM, scientific and medical journals questioned the vaccine’s safety.

Other Merck Vaccine Lawsuits

Zostavax claims are not the first lawsuits against Merck for faulty vaccines. In 2010, former Merck scientists filed a class action suit against the pharma giant. The lawsuit accused Merck of faking tests for the measles, mumps, rubella (MMR) vaccine.

The lawsuit said Merck lied to the FDA about the effectiveness of the company’s vaccine.

“The ultimate victims here are the millions of children who every year are being injected with a mumps vaccine that is not providing them with an adequate level of protection against mumps.”

Source: 2010 Merck Whistleblower Lawsuit

In 2012, a clinic and two other physicians sued Merck.

“Merck has known for a decade that its mumps vaccine is ‘far less effective’ than it tells the government,” the lawsuit claims. “… it falsified test results and sold millions of doses.”

Please seek the advice of a medical professional before making health care decisions.

Michelle Llamas, Senior Content Writer
Written By Michelle Llamas Senior Writer

Michelle Llamas has been writing articles and producing podcasts about drugs, medical devices and the FDA for seven years. She specializes in fluoroquinolone antibiotics, vaccines and products that affect women’s health such as Essure birth control, transvaginal mesh and talcum powder. Michelle collaborates with experts, including board-certified doctors, patients and advocates, to provide trusted health information to the public. Some of her qualifications include:

  • American Medical Writers Association (AMWA) Engage Committee and Membership Committee member
  • Centers for Disease Control and Prevention (CDC) Health Literacy certificates
  • Original works published or cited in The Lancet, British Journal of Clinical Pharmacology and the Journal for Palliative Medicine
Edited By
Kevin Connolly
Kevin Connolly Managing Editor
Legally Reviewed By
Dr. Joseph Palermo
Dr. Joseph Palermo Osteopathic Medicine

11 Cited Research Articles

  1. Centers for Disease Control and Prevention. (n.d.). CDC Seeks to Protect Older Adults With Shingles Vaccine Message. Retrieved from https://www.cdc.gov/vaccines/vpd-vac/shingles/downloads/shingles-vac-msg-2008.pdf
  2. U.S. Judicial Panel on Multidistrict Litigation. (2018, August 2). In Re: Zostavax (Zoster Vaccine Live) Products Liability Litigation. Transfer Order. MDL No. 2848. Retrieved from https://images.law.com/contrib/content/uploads/documents/402/24321/Shingles-MDL-order.pdf
  3. New Jersey Courts. (2018, August 24). Case Management Order 1. Retrieved from https://njcourts.gov/attorneys/assets/mcl/zostavax/orders/cmo1.pdf?cacheID=4T1h2iX
  4. Colamesta v. Merck et al. (2018, September 12). United States District Court For the District Of New Jersey. Complaint. Case No. 3:18-cv-13832. Retrieved from https://www.pacer.gov/
  5. Koleva, G. (2012, June 27). Merck Whistleblower Suit A Boon to Vaccine Foes Even As It Stresses Importance of Vaccines. Retrieved from https://www.forbes.com/sites/gerganakoleva/2012/06/27/merck-whistleblower-suit-a-boon-to-anti-vaccination-advocates-though-it-stresses-importance-of-vaccines/#1efee13c9678
  6. Sukkar v. Merck, et al. (2017, August 31). Superior Court of New Jersey Law Division: Middlesex County. Complaint and Jury Demand. Case No. MID-L-005192-17. Retrieved from https://www.judiciary.state.nj.us/courts/scco.html
  7. Packel, D. (2017, February 23). Merck Sued in Philly Over Shingles Vaccine Injuries. Retrieved from https://www.law360.com/articles/894995/merck-sued-in-philly-over-shingles-vaccine-injuries/
  8. Sagonowsky, E. (2017, March 14). Zostavax patients sue Merck, claiming shingles shot caused injuries and death. Retrieved from https://www.fiercepharma.com/vaccines/merck-targeted-zostavax-injury-suits
  9. Alliance for Human Research Protection. (n.d.). Former Merck Scientists Sue Merck Alleging MMR Vaccine Efficacy Fraud. Retrieved from http://ahrp.org/former-merck-scientists-sue-merck-alleging-mmr-vaccine-efficacy-fraud/
  10. Carroll, D.B. & Daly, D. (2018, September 18). New Jersey MCL Update: Three New Consolidated Litigations in New Jersey. Lexology. Retrieved from https://www.lexology.com/library/detail.aspx?g=f71cff51-32a1-4862-aa30-5b0f12bd2b6f
  11. U.S. Judicial Panel on Multidistrict Litigation. (2018, December 17). MDL Statistics Report - Distribution of Pending MDL Dockets by District. Retrieved from https://www.jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-December-17-2018.pdf 18.pdf
View All Sources
Who Am I Calling?

Calling this number connects you with one of Drugwatch's trusted legal partners. A law firm representative will review your case for free.

Drugwatch's sponsors support the organization’s mission to keep people safe from dangerous drugs and medical devices. For more information, visit our sponsors page.

(855) 415-4582